Related Experiment Video
Updated: May 10, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Early relapses, onset of progression, and late outcome in multiple sclerosis
Antonio Scalfari1, Anneke Neuhaus, Martin Daumer
1Centre for Neuroscience, Division of Experimental Medicine, Imperial College London, London, England.
Objectives:
To investigate the relationship among attacks in the first 2 years (early relapses), secondary progression (SP), and late disability in multiple sclerosis (MS).
Design:
Cohort study with follow-up of 28 years.
Setting:
Referral MS center.
Patients:
Patients (N=730) with relapsing-remitting MS diagnosed according to Poser criteria, from the database of the London Multiple Sclerosis Clinic, London, Ontario, Canada.
Main Outcome Measure:
Long-term evolution of patients with high (≥ 3 attacks) and early (within the first 2 years of the disease) frequency of relapses. In the total SP population and in patients grouped by numbers of early relapses, we assessed the predictive effect of latency to progression (time to SP) on times to attain cane requirement (Disability Status Scale score of 6 [DSS 6]) and bedridden status (DSS 8).
Results:
Among the group with frequent early relapses (n=158), outcomes were variable. Although 103 (65.2%) experienced rapid conversion to SP MS (median duration, 5 years) and rapidly attained DSS 6 and DSS 8 scores (7 and 17 years, respectively), the remainder (n=55) did not enter the SP phase, despite adverse early relapse features. Among the total SP population, longer latency to progression was associated with lower probability of attaining DSS 6 (odds ratio, 0.76 [95% CI, 0.69-0.84] and 0.44 [95% CI, 0.37-0.52] for 5- and 15-year latency, respectively) and longer times to severe disability. The same association between time to onset of SP and late outcomes was observed even in patients matched by number of early attacks. However, duration of the relapsing-remitting phase did not influence the times from SP onset to DSS levels.
Conclusions:
Our results indicate dissociation between early inflammatory attacks and onset of the SP phase and further question the validity of relapse frequency as a surrogate marker for late disability. Among the group with frequent early relapses, we observed a large variability of outcomes, ranging from one extreme to the opposite.
Insights
Early relapses in multiple sclerosis (MS) do not reliably predict secondary progression (SP) or long-term disability. Outcomes vary significantly, even in patients with frequent early attacks, questioning relapse frequency as a disability marker.
Area of Science:
- Neurology
- Neuroimmunology
- Clinical Neuroscience
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Understanding factors predicting disease progression is crucial for patient management.
- Early relapses and secondary progression (SP) are key clinical milestones in MS.
Purpose of the Study:
- To investigate the relationship between early relapses (first 2 years) and the onset of secondary progression (SP) in MS.
- To determine if early relapse frequency predicts long-term disability in MS patients.
- To assess the predictive value of time to SP on disability milestones.
Main Methods:
- A 28-year longitudinal cohort study of 730 patients with relapsing-remitting MS.
- Analysis of patients diagnosed using Poser criteria from the London Multiple Sclerosis Clinic database.
- Assessment of the impact of early relapse frequency and latency to SP on disability progression (cane requirement, bedridden status).
Main Results:
- Frequent early relapses (≥3 in 2 years) showed variable outcomes; 65.2% rapidly progressed to SP, while 34.8% did not, despite early inflammatory activity.
- Longer time to SP was associated with a lower probability of reaching significant disability (cane use, bedridden status).
- The duration of the relapsing-remitting phase did not affect the time from SP onset to severe disability.
Conclusions:
- Early inflammatory attacks in MS may be dissociated from the onset of secondary progression.
- Relapse frequency in the early disease course is not a reliable surrogate marker for predicting long-term disability.
- Significant outcome variability exists among MS patients, even those with frequent early relapses.
Related Concept Videos
Long-term Potentiation
Long-term Potentiation
Hebbian LTP
LTP can occur when presynaptic neurons...
Parkinson's Disease: Overview
Introduction to Language of Pathophysiology ll
Multiple Sclerosis l: Introduction
Secondary Spinal Cord Injury llI: Pathophysiology

